Whitepaper: Breaking Down the Hottest Topic in Pharmacy—Humira Biosimilars
RemedyOne cuts through the complexity of modern pharmaceutical programs to uncover opportunities to grow, to flex agreements in your favor and to help you take decisive action on what matters.
Rebate and Formulary Management
RemedyOne cuts through the complexity of the pharmaceutical world by providing guidance and cost savings to PBMs, Employer Groups, Health Plans, and Third-Party Administrators. Rebate and Formulary Management
RemedyOne cuts through the complexity of the pharmaceutical world by providing guidance and cost savings to PBMs, Employer Groups, Health Plans, and Third-Party Administrators.Insights
Breathing Easier: The Quest for Cost-Effective Asthma Care
Treating Mild to Moderate Asthma in Adolescence and Adults The objectives for treating moderate, persistent asthma in adolescents and adults…
Multiple Sclerosis: Evolving Approaches to Treatment
Regarded as the leading progressive neurological disease affecting young adults, multiple sclerosis (MS) often strikes during life’s pivotal moments—when individuals…
Weighing the Pros and Cons, and Dollars and Cents, of the New Wave of Weight-Loss Drugs
See this article by RemedyOne senior manager of formulary development Jason Peterson as it originally appeared in pharmaphorum and read…
Navigating the Dry Eye Landscape: Advances, Options, and Access
Have you ever had that annoying gritty feeling, like there’s sand trapped in your eyes? That’s just a glimpse of…
The Public Health Emergency Has Ended, Now What?
The Biden Administration ended the COVID-19 Public Health Emergency (PHE) on May 11, 2023. This marks over 3 years since…
Treating Hemophilia With Gene Therapy is a Powerful Option, But Patients Only Get One Chance
See this article by RemedyOne’s Jason Peterson as it originally appeared in Pharmaphorum. Gene therapy has emerged as a novel…
Like what you’re seeing?
Get more Insights sent to you.
